Document:

Document

Exhibit 10.18

NOTICE OF RESTRICTED STOCK UNIT AWARD
Nextdoor, Inc.
2018 Equity Incentive Plan
Terms defined in the Company’s 2018 Equity Incentive Plan (the “Plan”) shall have the same meanings in this Notice of Restricted Stock Unit Award (“Notice of Grant”). Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Notice of Grant. 
The Participant named below has been granted an award of restricted stock units (“RSUs”), subject to the terms and conditions of the Plan and the Restricted Stock Unit Agreement, attached as Annex A (the “RSU Agreement”) under the Plan, as follows: 
Participant Name:    
Address:    
Total Number of RSUs:    
RSU Grant Date:    
Vesting Commencement Date:    
Expiration Date: The earlier to occur of: (a) the date on which settlement of all vested RSUs granted hereunder occurs and (b) the tenth year following the RSU Grant Date.
Vesting:
For so long as Participant is in Continuous Service through each applicable date, RSUs will vest as follows:  (i) twenty-five percent (25%) of the RSUs subject to this award on the first anniversary of the Vesting Commencement Date, and (ii) an additional 1/16 of the RSUs thereafter on each subsequent February 15, May 15, August 15 and November 15 (each, a “Quarterly Vesting Date”).
“Continuous Service” means Participant continues to provide services as an employee, officer, director or consultant to the Company or a Parent or Subsidiary of the Company.
Settlement: RSUs shall be settled no later than March 15 of the calendar year following the calendar year in which each Vesting Event occurs.  Settlement means the delivery of the Shares vested under an RSU.  Settlement of RSUs shall be in Shares.  Settlement of vested RSUs shall occur whether or not Participant is in Continuous Service at the time of settlement.  No fractional RSUs or rights for fractional Shares shall be created pursuant to this Notice of Grant.  
Participant understands that Participant’s employment or consulting relationship with the Company is for an unspecified duration, can be terminated at any time (i.e., is “at-will”) and that nothing in this Notice of Grant, the RSU Agreement or the Plan changes the at-will nature of that relationship.  Participant also understands that this Notice of Grant is subject to the terms and conditions of both the RSU Agreement and the Plan, each of which are incorporated herein by reference.  Participant has read both the RSU Agreement and the Plan.
Execution and Delivery:  This Notice of Grant may be executed and delivered electronically whether via the Company’s intranet or the Internet site of a third party or via email or any other means of electronic delivery specified by the Company.  By Participant’s acceptance hereof (whether written, electronic or otherwise), 

Participant agrees, to the fullest extent permitted by law, that in lieu of receiving documents in paper format, Participant accepts the electronic delivery of any documents the Company, or any third party involved in administering the Plan which the Company may designate, may deliver in connection with this grant (including the Plan, the Notice of Grant, this RSU Agreement, any disclosures provided pursuant to Rule 701, account statements or other communications or information) whether via the Company’s intranet or the internet site of another third party or via email, or  other means of electronic delivery specified by the Company.
By Participant’s and the Company’s acceptance hereof (in each case, whether written, electronic or otherwise), Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice of Grant and the RSU Agreement.
-2-

ANNEX A
RESTRICTED STOCK UNIT AGREEMENT
Participant has been granted RSUs subject to the terms, restrictions and conditions of the Company’s 2018 Equity Incentive Plan (the “Plan”), the Notice of Restricted Stock Unit Award (“Notice of Grant”) and this Restricted Stock Unit Agreement (this “Agreement”).  Unless otherwise defined herein or in the Notice of Grant, the terms defined in the Plan shall have the same defined meanings in this Agreement.
1.    No Stockholder Rights.  Until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote such Shares.  As a condition to the issuance of any Shares in settlement of vested RSUs, Participant agrees to enter into a joinder to be bound by any stockholders’ agreement by and between the Company and its stockholders in force from time to time.
2.    Dividend Equivalents.  Dividend equivalents, if any, shall not be credited to Participant in respect of Participant’s RSUs, except as otherwise permitted by the Committee.
3.    No Transfer.  The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of, other than by will or by the laws of descent and distribution.  Any transferee who receives an interest in the RSU or the underlying Shares upon the death of Participant shall acknowledge in writing that the RSU shall continue to be subject to the restrictions set forth in this Section 3.
4.    Termination.  The RSUs shall terminate on the Expiration Date or earlier as provided in this Section 4. If Participant’s Continuous Service with the Company terminates for any reason, all RSUs for which vesting is no longer possible under the terms of the Notice of Grant and this Agreement shall be forfeited to the Company forthwith, and all rights of Participant to the RSUs shall immediately terminate.  In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether Termination has occurred and the effective date of such Termination
5.    Acknowledgement.  The Company and Participant agree that the RSUs are granted under and governed by the Notice of Grant, this Agreement, and the provisions of the Plan (incorporated herein by reference).  Participant (i) acknowledges receipt of a copy of each of the foregoing documents, (ii) represents that Participant has carefully read and is familiar with their provisions and (iii) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.
6.    Limitations on Transfer of Stock. In addition to any other limitation on transfer created by applicable securities laws, Participant shall not assign, encumber or dispose of any interest in the Shares issued pursuant to this Agreement except with the Company’s prior written consent and in compliance with the Plan, the Company’s then-current insider trading policy and applicable securities laws.  The restrictions on transfer also include a prohibition on any short position, any “put equivalent position” or any “call equivalent position” by the RSU holder with respect to the RSU itself as well as any shares issuable upon settlement of the RSU prior to the settlement thereof until the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”).
7.    Restrictions Binding on Transferees.  All transferees of Shares or any interest therein will receive and hold such shares or interest subject to the provisions of this Agreement, including the transfer restrictions of Sections 3 and 6, and the transferee shall acknowledge the restrictions in writing.  Any sale or transfer of the Shares shall be void unless the provisions of this Agreement are satisfied.

8.    Withholding of Tax.  When the RSUs are vested and/or settled, the fair market value of the Shares shall be treated as income subject to withholding by the Company for income and employment taxes if Participant is or was an employee of the Company.  Prior to any relevant taxable or tax withholding event, as applicable, Participant shall pay or make adequate arrangements satisfactory to the Company to satisfy any or all income tax, social insurance, payroll tax, fringe benefits tax, payment on account and other tax-related items related to the Participant’s participation in this Plan and legally applicable to the Participant (collectively, “Tax-Related Obligations”).  In this regard, Participant authorizes the Company to withhold all applicable Tax-Related Obligations legally payable by Participant from Participant’s wages or other cash compensation paid to Participant by the Company and/or a Parent or Subsidiary of the Company.  With the Company’s consent, these arrangements may also include, if permissible under local law, (i) withholding Shares that otherwise would be issued to Participant when Participant’s RSUs are settled; (ii) having the Company withhold taxes from the proceeds of the sale of the Shares, through a voluntary sale or through a mandatory sale arranged by the Company (on Participant’s behalf and Participant hereby authorizes such sales by this authorization); (iii) Participant’s payment of a cash amount; or (iv) any other arrangement approved by the Company; all under such rules as may be established by the Committee and in compliance with the Company’s insider trading policy and 10b5-1 trading plan policy, if applicable; provided, however, that if Participant is a Section 16 officer of the Company under the Exchange Act, then the method of withholding shall be through a mandatory sale under (ii) above, and as to minimum statutory withholding rates only.  Depending on the withholding method, the Company and/or a Parent or Subsidiary of the Company may withhold or account for Tax-Related Obligations by considering applicable minimum statutory withholding rates or other applicable withholding rates, including maximum applicable rates, in which case Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent in Shares.  In the case of withholding in Shares, the Company shall issue the net number of Shares to Participant by deducting the Shares retained for Tax-Related Obligations from the Shares issuable upon vesting.  For tax purposes, Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Obligations.  
9.    Code Section 409A.  For purposes of this Agreement, a termination of employment will be determined consistent with the rules relating to a “separation from service” as defined in Section 409A of the Code and the regulations thereunder (“Section 409A”).  Notwithstanding anything else provided herein, to the extent any payments provided under this Agreement in connection with Participant’s termination of employment constitute deferred compensation subject to Section 409A, and Participant is deemed at the time of  Termination of employment to be a “specified employee” under Section 409A, then the payment shall not be made or commence until the earlier of (i) the expiration of the six-month period measured from Participant’s separation from service from the Company or (ii) the date of Participant’s death following a separation from service; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Participant including, without limitation, the additional tax for which Participant would otherwise be liable under Section 409A(a)(1)(B) in the absence of such a deferral.  The first payment thereof will include a catch-up payment covering the amount that would have otherwise been paid during the period between Participant’s termination of employment and the first payment date but for the application of this provision, and the balance of the installments (if any) will be payable in accordance with their original schedule.  To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A, the provision will be read in such a manner so that all payments hereunder comply with Section 409A.  To the extent any payment under this Agreement may be classified as a “short-term deferral” within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from Section 409A under another provision of Section 409A.  Payments pursuant to this section are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.
-2-

10.    Tax Consequences.  Participant acknowledges that there will be tax consequences upon vesting and/or settlement of the RSUs and/or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant’s tax obligations prior to the settlement or disposition.
11.    Compliance with Laws and Regulations.  The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant (including any written representations, warranties and agreements as the Committee may request of Participant for compliance with applicable laws) with all applicable foreign and US state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company’s capital stock may be listed or quoted at the time of the issuance or transfer.  Participant may not be issued any Shares if the issuance would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the capital stock may then be listed.  The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any Shares shall relieve the Company of any liability in respect of the failure to issue or sell the shares.
12.    Legend on Certificates.  The certificates representing the Shares issued hereunder shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan, this Agreement or the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange upon which such shares of the Company’s Common Stock are listed and any applicable federal or state laws, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions.
13.    Successors and Assigns.  The Company may assign any of its rights under this Agreement.  This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon Participant and Participant’s heirs, executors, administrators, legal representatives, successors and assigns.
14.    Entire Agreement; Severability.  The Plan and the Notice of Grant are incorporated herein by reference.  The Plan, the Notice of Grant and this Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof (including, without limitation, any commitment to make any other form of equity award (such as stock options) that may have been set forth in any employment offer letter or other agreement between the parties).  If any provision of this Agreement is determined by a court of law to be illegal or unenforceable, then such provision will be enforced to the maximum extent possible and the other provisions will remain fully effective and enforceable.
15.    Market Standoff Agreement.  Participant agrees that, subject to any early release provisions that apply pro rata to stockholders of the Company according to their holdings of Common Stock (determined on an as-converted into Common Stock basis), Participant will not, for a period of up to one hundred eighty (180) days (plus up to an additional thirty five (35) days to the extent reasonably requested by the Company or such underwriter(s) to accommodate regulatory restrictions on the publication or other distribution of research reports or earnings releases by the Company, including NASD and NYSE rules) following the effective date of the registration statement filed with the SEC relating to the IPO, directly or indirectly sell, offer to sell, grant any option for the sale of, or otherwise dispose of any Common Stock or securities convertible into Common Stock, except for: (i) transfers of Shares permitted under Section 6 hereof so long as such transferee furnishes to the Company and the managing underwriter their written consent to be bound by this Section 15 as a condition precedent to such transfer; and (ii) sales of any securities to be included in the registration statement for the IPO.  For the avoidance of doubt, the provisions of this Section shall only apply 
-3-

to the IPO.  The restricted period shall in any event terminate two (2) years after the closing date of the IPO.  In order to enforce the foregoing covenant, the Company shall have the right to place restrictive legends on the certificates representing the Shares subject to this Section and to impose stop transfer instructions with respect to the Shares until the end of such period.  Participant further agrees to enter into any agreement reasonably required by the underwriters to implement the foregoing restrictions on transfer.  For the avoidance of doubt, the foregoing provisions of this Section shall not apply to any registration of securities of the Company (a) under an employee benefit plan or (b) in a merger, consolidation, business combination or similar transaction.
16.    No Rights as Employee, Director or Consultant.  Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant’s Continuous Service, for any reason, with or without cause.
17.    Information to Participants.  If the Company is relying on an exemption from registration under Section 12(h)-1 of the Exchange Act and such information is required to be provided by Section 12(h)-1, the Company shall provide the information described in Rules 701(e)(3), (4) and (5) of the Securities Act by a method allowed under Section 12(h)-1 of the Exchange Act in accordance with Section 12(h)-1 of the Exchange Act, provided, that Participant agrees to keep the information confidential.
18.    Delivery of Documents and Notices.  Any document relating to participating in the Plan and/or notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery or deposit in the U.S. Post Office or foreign postal service, by registered or certified mail, with postage and fees prepaid, addressed to the other party at the e-mail address, if any, provided for Participant by the Company or at such other address as such party may designate in writing from time to time to the other party.
19.    Choice of Law and Venue.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, as such laws are applied to contracts entered into and performed in such State.  For purposes of any action, lawsuit or other proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the courts of San Francisco County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.
* * * * * * * * * *
-4-Exhibit 10.2

 

INTENSITY THERAPEUTICS, INC.

 

2013 STOCK AND OPTION PLAN

 

SECTION 1

 

TITLE

 

This Plan shall be known as the Intensity Therapeutics, Inc.
2013 Stock and Option Plan.

 

SECTION 2

 

PURPOSE

 

The purpose of the
Plan is to advance the interests of the Company by providing key employees and certain other persons with opportunities to participate
in the ownership of the Company and its future growth through (a) the grant of options which qualify as “incentive stock options”
under Section 422(b) of the Code; (b) the grant of options which do not qualify as ISOs and (c) other stock based awards.

 

SECTION 3

 

DEFINITIONS

 

As used in the Plan, the following capitalized words shall
have the meanings indicated:

 

3.1 “Award”
means, individually or collectively, a grant under the Plan of Options or Restricted Stock, or any other equity-based Award made pursuant
to Section 9 below.

 

3.2 “Award Agreement”
means the written agreement setting forth the terms and provisions applicable to an Award granted under the Plan.

 

3.3 “Board” means the Board of Directors
of the Company.

 

3.4 “Code” means the Internal Revenue
Code of 1986, as amended.

 

3.5 “Committee”
means one or more committees each comprised of not less than two members of the Board appointed by the Board to administer the Plan or
a specified portion thereof.

 

3.6 “Common Stock” means the Company’s
common stock, par value $0.0001 per share.

 

3.7 “Company” means Pennant Co, a Delaware
corporation, or any successor thereto.

 

3.8 “Disability” means “disability,”
as such term is defined in Section 22(e)(3) of the Code.

 

    

    

    

 

3.9 “Disqualifying
Disposition” means any disposition (within the meaning of Section 424(c) of the Code) of Shares acquired upon the exercise
of an ISO before the later of (a) two years after the Participant was granted the ISO or (b) one year after the Participant acquired
the Shares by exercising the ISO.

 

3.10 “Fair
Market Value” means, with respect to a Share as of any date of determination, in the discretion of the Committee, (i) the average
(on that date) of the high and low prices of the Common Stock on the principal national securities exchange on which the Common Stock
is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date)
of the Common Stock on the NASDAQ Stock Market, if the Common Stock is not then traded on a national securities exchange; or (iii) the
closing bid price (or average of bid prices) last quoted (on that date) by an established quotation service for over-the-counter securities,
if the Common Stock is not reported on the NASDAQ Stock Market; or (iv) if Shares are not publicly traded, the fair market value of such
Share as determined by the Board in good faith after taking into consideration all facts which it deems appropriate and in accordance
with applicable statutory and regulatory guidelines.

 

3.11 “Grant
Date” means the effective date of an Award as specified by the Committee and set forth in the applicable Award Agreement.

 

3.12 “Incentive
Stock Option” or “ISO” means an option to purchase Shares awarded to a Participant under Section 7 of the Plan
that is intended to meet the requirements of Section 422 of the Code.

 

3.13 “Initial
Public Offering” means the first public offering of the Company’s equity securities registered under the Securities Act,
or any successor statute, or such other event as a result of which outstanding equity securities of the Company (or any successor entity)
shall be publicly traded.

 

3.14 “Non-Qualified
Option” or “NQO” means an option to purchase Shares awarded to a Participant under Section 7 of the Plan that is
not intended to be an ISO.

 

3.15 “Option” means an ISO or an NQO.

 

3.16 “Participant”
means an individual or entity selected by the Committee to receive an Award under the Plan.

 

3.17 “Plan”
means the Intensity Therapeutics, Inc. 2013 Stock and Option Plan set forth in this document and as hereafter amended from time to time
in accordance with Section 12.

 

3.18 “Restricted
Stock” means Shares awarded to a Participant under Section 8 of the Plan pursuant to an Award that entitles the Participant
to acquire Shares for a purchase price (which may be zero if permissible under applicable law), subject to such conditions as the Committee
may determine to be appropriate, including a Company right during a specified period or periods to repurchase the Shares at their original
purchase price (or to require forfeiture of the Shares if the purchase price was zero and if permissible under applicable law) upon conditions
specified in connection with the Award.

 

    - 2 -

    

    

  

3.19 “Securities Act” means the Securities
Act of 1933, as amended.

 

3.20 “Shares” means shares of the Company’s
Common Stock.

 

SECTION 4

 

ADMINISTRATION

 

4.1 Administrator.
The Plan shall be administered by the Committee, or if there is no Committee, by the Board. All references in this Plan to the “Committee”
shall mean the Board if no Committee has been appointed.

 

4.2 Duties
of Administrator. Subject to ratification of the grant or authorization of each Award by the Committee (if so required by
applicable state law), and subject to the terms of the Plan, the Committee shall have the authority to (i) determine to whom (from
among the class of persons eligible under Section 5 to receive Awards) Awards shall be granted; (ii) determine the time or times at
which Awards shall be granted; (iii) determine the purchase price of Shares subject to each Award; (iv) determine whether each
Option granted shall be an ISO or a NQO; (v) determine the time or times when each Award shall become exercisable or vested and the
duration of the exercise or vesting period; (vi) determine any other provisions applicable to the Award and the shares of Common
Stock issuable upon exercise thereof; (vii) interpret the Plan and prescribe and rescind rules and regulations relating to it; and
(viii) make all other determinations necessary or advisable for administration of the Plan. The interpretation and construction by
the Committee of any provisions of the Plan or of any Award granted under it shall be final and conclusive unless otherwise
determined by the Committee. The Committee may from time to time adopt such rules and regulations for carrying out the Plan as it
may deem advisable. No member of the Board or the Committee nor any officer, director, employee or agent of the Company shall be
liable for any action or determination made in good faith with respect to the Plan or any Award granted under it.

 

SECTION 5

 

ELIGIBILITY

 

The Committee may grant
Awards to those employees, officers, directors, consultants and advisors whom the Committee, in its sole discretion, identifies as being
in a position which enables such individuals to contribute to the continued growth, development and future financial success of the Company.
A director, officer or other person who is not also an employee of the Company shall not be eligible to receive an ISO. The granting of
any Award to any individual shall neither entitle that individual to, nor disqualify him or her from, participation in any other grant
of Awards.

 

    - 3 -

    

    

 

SECTION 6

 

STOCK RESERVED FOR AWARDS

 

6.1 Aggregate
Number of Shares Available for Awards. Subject to adjustment as provided in Section 10, the maximum number of Shares to be reserved
for issuance under the Plan as Awards, including Incentive Stock Options, shall be One Hundred Fifty Thousand (150,000) Shares. Any or
all of the Shares subject to Awards under the Plan may be authorized but unissued Shares, or issued Shares that have been or shall have
been reacquired by the Company, as the Board may from time to time determine.

 

6.2 Lapsed, Forfeited
or Expired Awards. If any Award granted under the Plan shall expire or terminate for any reason without having been exercised in
full or shall cease for any reason to be exercisable in whole or in part, the unpurchased shares subject to such Award shall again be
available for grants of Awards under the Plan unless the Plan shall have been terminated.

 

SECTION 7

 

STOCK OPTIONS

 

7.1 Grant of Options.
Subject to the limitations ofthe Plan, the Committee may, after consultation with and consideration of the recommendations of management
and the Board as the Committee deems desirable, select those individuals to be granted Options and determine the time when each such
Option shall be granted and such other terms of each Option. The Committee shall clearly designate and identify each Option at the time
it is granted as either an ISO or a Non-Qualified Option, as the case may be. The Grant Date of an Option under the Plan will be the
date specified by the Committee at the time it grants the Option; provided, however, that such date shall not be prior to the date on
which the Committee acts to approve the grant. ISOs may be granted only to persons who are employees ofthe Company on the Grant Date.
The Company shall have no liability to a Participant or to any other party if an Option (or any portion thereof) that is intended to
be an ISO is determined not to be an ISO (including, without limitation, due to the determination that the exercise price per share of
the Option was less than the fair market value per share as of the Grant Date). The Committee may grant both ISOs and NQOs to the same
employee, and the exercise of one such Option does not in any way affect the employee’s right to exercise the other.

 

7.2 Exercise Price.
Unless the Committee determines otherwise, the exercise price specified in the Option Agreement relating to each Option granted under
the Plan shall be not less than one hundred percent (100%) of the Fair Market Value on the Grant Date. In the case of an ISO, the exercise
price of an ISO shall be not less than 100% of the Fair Market Value on the Grant Date; provided however that if on the Grant Date, the
Participant owns or is deemed to own (by reason of the attribution rules of Section 424( d) of the Code) stock possessing more than ten
percent (1 0%) of the total combined voting power of all classes of stock of the Company or any parent or subsidiary, the exercise price
per share specified in the agreement relating to such ISO shall not be less than one hundred ten percent (110%) of the Fair Market Value
per share of Common Stock on the Grant Date.

 

    - 4 -

    

    

 

7.3 Exercise
of Options. Options shall become exercisable or vested at such time or times as shall be determined by the Committee at or after
the Grant Date. The Committee may at any time accelerate the exercisability or vesting of all or any portion of any Option.

 

7.4 Method of Exercise.
An Option (or any part or installment thereof) shall be exercised by giving written notice to the Company at its principal office address,
or to such transfer agent as the Company shall designate. Such notice shall identify the Option being exercised and specify the number
of shares as to which such Option is being exercised, accompanied by full payment of the purchase price therefore either (a) in United
States dollars in cash or by check, (b) subject to the Committee’s discretion at the time of exercise, by the Optionee’s
full recourse promissory note in a form approved by the Committee, (c) subject to the Committee’s discretion, delivery of a properly
executed exercise notice together with irrevocable instructions to a broker to deliver to the Company promptly the amount of the proceeds
of the sale of all or a portion of the Shares issued upon exercise of the Option or of a loan from the broker to the Optionee required
to pay the exercise price, (d) subject to the Committee’s discretion at the time of exercise, by tender to the Company of Common
Stock owned by the Optionee, having a Fair Market Value on the date of tender not less than the exercise price, (e) by retention of shares
from the Award being exercised, or (f) at the discretion of the Committee, by any combination of the above.

 

7.5 Option Term.
The term of each Option shall be fixed by the Committee; provided however that no Option shall be exercisable more than ten (1 0) years
after the date the Option is granted provided, further that if an ISO is granted to an Participant who, together with persons whose stock
ownership is attributed to the Participant pursuant to Section 424( d) of the Code, owns stock possessing more than ten percent (10%)
of the total combined voting power of all classes of stock of the Company, the ISO may not be exercised after the expiration of five
(5) years from the Grant Date.

 

7.6. Annual Limit on
Incentive Stock Options. Each eligible employee may be granted Options treated as ISOs only to the extent that, in the aggregate
under this Plan and all incentive stock option plans of the Company, ISOs do not become exercisable for the first time by such employee
during any calendar year with respect to stock having a fair market value (determined at the time the ISOs were granted) in excess of
$100,000. The Company intends to designate any Options granted in excess of such limitation as NQOs.

 

7.7 Termination of Employment, Death and Disability.

 

7.7.1 ISO.
Unless otherwise specified in the agreement relating to such ISO, if a Participant ceases to be employed by the Company (including retirement)
other than by reason of death or Disability, no further installments of his or her ISOs shall become exercisable, and his or her ISOs
shall terminate on the earlier of (a) ninety (90) days after the date of termination of his or her employment provided, however,
if such termination occurs by reason of death or Disability, such period shall be extended to one (1) year following the date of such
event, or (b) their specified expiration dates, except to the extent that such ISOs (or unexercised installments thereof) have been converted
into Non-Qualified Options pursuant to Section 7.8 hereof.

 

    - 5 -

    

    

 

7.7.2 Non-Qualified
Option. The Committee, in its discretion, shall determine the extent, if any, to which the grantee of a Non-Qualified Option may
exercise said Option upon his or her termination of employment with the Company. If not otherwise specified in the Award Agreement, a
Non-Qualified Option must be exercised no later  than the thirtieth (30th) day after the Participant’s cessation of
service with the Company.

 

7.7.3 Leave
of Absence. For purposes of this Section, employment shall be considered as continuing uninterrupted during any bona fide leave of
absence (such as those attributable to illness, military obligations or governmental service) provided that the period of such leave
does not exceed ninety (90) days or, if longer, any period during which such Participant’s right to reemployment is guaranteed
by statute. A bona fide leave of absence with the written approval of the Committee shall not be considered an interruption of employment,
provided that such written approval contractually obligates the Company to continue the employment of the Participant after the approved
period of absence.

 

7.8 Transferability
of Options. Except as otherwise provided in an Award Agreement pertaining to NQOs, no Option shall be assignable or transferable
by the grantee except by will or by the laws of descent and distribution nor shall an Option be subject to attachment, execution or similar
process. Except as set forth in the previous sentence and except as otherwise provided in an Award Agreement pertaining to NQOs, during
the lifetime of a grantee, each Option shall be exercisable only by such grantee. In the event of (a) any attempt by the Participant
to alienate, assign, pledge, hypothecate or otherwise dispose of the Option, except as provided in this Plan, or (b) the levy of any
attachment, execution or similar process upon the rights or interest hereby conferred, the Company may terminate the Option by notice
to the Participant and it shall thereupon become null and void.

 

7.9 Conversion of ISOs
to Non-Qualified Options. The Committee, at the written request or with the written consent of any Participant, may in its discretion
take such actions as may be necessary to convert such Participant’s ISOs (or any installments or portions of installments thereof)
that have not been exercised on the date of conversion into Non-Qualified Options at any time prior to the expiration of such ISOs, regardless
of whether the Participant is an employee of the Company at the time of such conversion. Such actions may include, but shall not be limited
to, extending the exercise period or reducing the exercise price of the appropriate installments of such ISOs. At the time of such conversion,
the Committee (with the consent of the Participant) may impose such conditions on the exercise of the resulting Non-Qualified Options
as the Committee in its discretion may determine, provided that such conditions shall not be inconsistent with this Plan. Nothing in
the Plan shall be deemed to give any Participant the right to have such Participant’s ISOs converted into Non-Qualified Options,
and no such conversion shall occur until and unless the Committee takes appropriate action.

 

    - 6 -

    

    

 

7.10 Cancellation
of Options. Except as otherwise expressly provided in the agreement pursuant to which an Option is issued, the Committee may, in
its sole discretion, in cases involving a serious breach of conduct by an employee or former employee, or activity of a former employee
in competition with the business of the Company, cancel any Option, whether vested or not, in whole or in part. Such cancellation shall
be effective as of the date specified by the Committee.

 

SECTION 8

 

RESTRICTED STOCK

 

8.1 Grant of
Restricted Stock. The Committee may award shares of Restricted Stock and determine the purchase price, if any, therefor, the duration
of the restricted period during which the shares are subject to forfeiture or restrictions on transferability, if any, the conditions,
if any, under which the Shares may be forfeited to or repurchased by the Company and any other terms and conditions of the Awards. The
Committee may modify or waive any restrictions, terms and conditions with respect to any Restricted Stock. Shares of Restricted Stock
may be issued for such consideration, if any, as is determined by the Committee, subject to applicable law.

 

8.2 Transferability.
Except as set forth in the applicable Award Agreement, Shares of Restricted Stock may not be sold, assigned, transferred, pledged or
otherwise encumbered. Furthermore, the Award of Shares of Restricted Stock may be made subject to a repurchase right or right of first
refusal, with respect to the Shares of Restricted Stock, in favor of the Company and certain stockholders of the Company upon the occurrence
of certain specified events.

 

8.3 Evidence of Award.
Shares of Restricted Stock shall be evidenced in such manner as the Committee may determine. Any certificates issued in respect of Shares
of Restricted Stock shall be registered in the name of the Participant and, unless otherwise determined by the Committee, deposited by
the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the restricted
period(s), the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant.

 

8.4 Shareholder Rights.
A Participant shall have all the rights of a shareholder with respect to Restricted Stock awarded, including voting and dividend rights,
unless otherwise provided in the Award Agreement.

 

SECTION 9

 

OTHER STOCK-BASED AWARDS

 

The Committee shall have
the right to grant other Awards based upon the Common Stock having such terms and conditions as the Committee may determine, including,
without limitation, the grant of Shares based upon certain conditions, the grant of securities convertible into Common Stock and the grant
of stock appreciation rights.

 

    - 7 -

    

    

 

SECTION 10

 

ADJUSTMENTS UPON CHANGES IN CAPITALIZATION
AND “TERMINATING

TRANSACTION” EVENTS

 

10.1 Upon the occurrence
of any of the following events, a Participant’s rights with respect to Awards granted to such participant hereunder shall be adjusted
as hereinafter provided, unless otherwise specifically provided in the Award Agreement:

 

10.1.1 Recapitalization
or Reorganization. Subject to Section 10.1.2 below, if, as a result of any recapitalization, reorganization, reclassification,
stock dividend, stock split, reverse stock split or other similar change in the Company’s capital stock, the outstanding
shares of Stock are increased or decreased or are exchanged for a different number or kind of shares or other securities of the
Company, or additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed
with respect to such Shares or other securities, or, if, as a result of any merger, consolidation or sale of all or substantially
all of the assets of the Company, the outstanding shares of Stock are converted into or exchanged for a different number or kind of
securities of the Company or any successor entity (or a parent or subsidiary thereof), the Committee shall make an appropriate or
proportionate adjustment in (i) the maximum number of shares reserved for issuance under the Plan; (ii) the number and kind of
shares or other securities subject to any then outstanding Awards under the Plan; (iii) the repurchase price per share subject to
each outstanding Award, if any; and (iv) the exercise price and/or exchange price for each share subject to any then outstanding
Options under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of Options)
as to which such Options remain exercisable. The adjustment by the Committee shall be final, binding and conclusive. No fractional
shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a
cash payment in lieu of fractional shares. The Committee may also adjust the number of shares subject to outstanding Awards and the
exercise price and the terms of outstanding Awards to take into consideration material changes in accounting practices or
principles, extraordinary dividends, acquisitions or dispositions of stock or property or any other event if it is determined by the
Committee that such adjustment is appropriate to avoid distortion in the operation of the Plan, provided that no such adjustment
shall be made in the case of an Incentive Stock Option, without the consent of the grantee, if it would constitute a modification,
extension or renewal of the Option within the meaning of Section 424(h) of the Code.

 

    - 8 -

    

    

 

10.1.2 Change
in Control. Notwithstanding any other provision of the Plan, but subject to the provisions of any particular Award Agreement, in
the event of any Change in Control (as defined below) of the Company, and in anticipation thereofifrequired by the circumstances,
the Committee, in its sole discretion (and in addition to or in lieu of any actions permitted to be taken by the Company under the
terms of any particular Award Agreement), may, on either an overall or a Participant by Participant basis, (i) accelerate the
exercisability or vesting, prior to the effective date of such Change in Control, of any outstanding Options (and/or terminate the
restrictions applicable to any Shares of Restricted Stock); (ii) upon written notice, provide that any outstanding Options must
be exercised, to the extent then exercisable, within a specified number of days after the date of such notice, at the end of which
period such Options shall terminate; (iii) if there is a surviving or acquiring entity, and subject to the consummation of such
Change in Control, cause that entity or an affiliate of that entity to grant replacement Awards having such terms and conditions as
the Committee determines to be appropriate in its sole discretion, upon which replacement the replaced Options or Restricted Stock
shall be terminated or cancelled, as the case may be; (iv) terminate any outstanding Options and make such payments, if any,
therefor (or cause the surviving or acquiring entity to make such payments, if any, therefor) as the Committee determines to be
appropriate in its sole discretion (including, without limitation, with respect to only the then exercisable or vested portion of
such Options based on the Fair Market Value of the underlying Shares as determined by the Board in good faith), upon which
termination such Options shall immediately cease to have any further force or effect; (v) repurchase (or cause the surviving or
acquiring entity to purchase) any Shares of Restricted Stock for such amounts, if any, as the Board determines to be appropriate in
its sole discretion (including, without limitation, an amount with respect to only the vested portion of such Shares (i.e., the
portion that is not then subject to forfeiture or repurchase at a price less than their value), based on the Fair Market Value of
such vested portion as determined by the Board in good faith), upon which purchase the holder of such Shares shall surrender such
Shares to the purchaser; or (vi) take any combination (or none) of the foregoing actions. For purposes of this Plan, a “Change
in Control” shall mean a single transaction or series of related transactions, other than an Initial Public Offering, pursuant
to which a person or persons, other than existing stockholders of the Company (i) acquires capital stock of the Company possessing
the voting power to elect a majority of the Board; (ii) consummates a merger, amalgamation or consolidation with the Company as a
result of which the stockholders of the Company who own common stock or other voting securities prior to such transaction(s) shall
own, directly or indirectly, less than fifty percent (50%) of the voting securities of the surviving entity; or (iii) acquire all or
substantially all of the assets of the Company.

 

10.1.3 Dissolution
or Liquidation. In the event of the proposed dissolution or liquidation of the Company, each A ward will terminate immediately prior
to the consummation of such proposed action or at such other time and subject to such other conditions as shall be determined by the
Committee.

 

10.2 Assumption of Options
Upon Certain Events. In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company
of property or stock of an entity, the Committee may grant Awards under the Plan in substitution for stock and stock based awards issued
by such entity or affiliate thereof.

 

10.3 No Effect.
Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares
of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares
subject to Options. No adjustments shall be made for dividends paid in cash or in property other than securities of the Company.

 

    - 9 -

    

    

 

10.4 Appropriate
Adjustments. Upon the happening of any of the events described in Section 10.1 above, the class and aggregate number of shares set
forth in Section 6 hereof that are subject to Options which previously have been or subsequently may be granted under the Plan shall
also be appropriately adjusted to reflect the events described in such subparagraphs. The Committee or the Board shall determine the
specific adjustments to be made under this Section 10 and, subject to Section 3, its determination shall be conclusive.

 

SECTION 11

 

GENERAL PROVISIONS APPLICABLE TO AWARDS

 

11.1 Withholding,
Requirements and Arrangements. The Participant shall pay to the Company, or make provision satisfactory to the Board for payment
of, any taxes required to be withheld in respect of any Option no later than the date of the event creating the tax liability. In the
Board’s discretion, such tax obligations may be paid in whole or in part in Shares, including shares retained from the exercise
of the Option creating the tax obligation, valued at the Fair Market Value of the Shares on the date of delivery to the Company. The
Company and any of its affiliates may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise
due to the Participant.

 

11.2 No Effect
on Employment. The Plan shall not give rise to any right on the part of any Participant to continue in the employ of the Company.
The loss of existing or potential profit in Awards granted under the Plan shall not constitute an element of damages in the event of
termination of the relationship of a Participant even if the termination is in violation of an obligation of the Company to the Participant
by contract or otherwise.

 

11.3 No Rights
as Shareholder. Subject to the provisions of the Plan and the applicable Award Agreement, no Participant shall have any rights as
a shareholder with respect to any Shares to be distributed under the Plan until he or she becomes the holder thereof.

 

11.4 Lock-Up
Agreement. The Company may, in its discretion, require in connection with an Initial Public Offering that a Participant agree that
any Share not be sold, offered for sale, or otherwise disposed of for a period of time as determined by the Committee, provided at least
a majority of the Company’s Directors and officers who hold Shares or Options at such time are similarly bound.

 

11.5 Governing Law.
The Plan and all rights under the Plan shall be construed in accordance with and governed by the internal laws of the Delaware, without
giving effect to the principles of the conflicts of laws thereof.

 

11.6 Effective Date.
The Plan shall become effective on the date on which it is adopted by the Board. No Awards shall be granted under the Plan after the
completion of ten years from the earlier of (i) the date on which the Plan was adopted by the Board; or (ii) the date the Plan was approved
by the Company’s stockholders, but Awards previously granted may extend beyond that date.

 

    - 10 -

    

    

 

11.7 Waiver.
Any provision for the benefit of the Company contained in this Plan may be waived, either generally or in any particular instance, by
the Board of Directors of the Company.

 

11.8 Notice.
All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after
deposit in the United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the
address shown beneath his or her respective signature to this Plan, or at such other address or addresses as a party shall designate
in accordance with this Section 11.8.

 

11.9 Titles
and Subtitles. The titles of the sections and subsections of this Plan are for convenience of reference only and are not to be considered
in construing this Plan.

 

11.10 Severability.
The invalidity or unenforceability of any provision of this Plan shall not affect the validity or enforceability of any other provision
of this Plan, and each other provision of this Plan shall be severable and enforceable to the extent permitted by law.

 

SECTION 12

 

AMENDMENT AND TERMINATION

 

12.1 Amendment, Suspension,
Termination of the Plan. The Board may amend, suspend or terminate the Plan in whole or in part at any time and for any reason. No
amendment, suspension or termination of the Plan shall materially adversely affect the rights of a Participant, without such Participant’s
consent, with respect to any Award previously made. Unless terminated earlier by the Board, the Plan shall terminate on the tenth anniversary
of the Plan’s date of adoption by the Board. In no event shall any Awards be made under the Plan after such expiration date, but
Awards previously granted may extend beyond such date.

 

12.2 Amendment, Suspension,
Termination of an Award. The Committee may modify, amend or terminate any outstanding Award, including, without limitation, substituting
therefor another Award of the same or a different type and changing the date of exercise or realization; provided, however, that the
Participant’s consent to such action shall be required unless the Committee determines that the action, taking into account any
related action, would not materially adversely affect the Participant.

 

DATE APPROVED BY BOARD OF DIRECTORS: August 14, 2013

 

DATE APPROVED BY STOCKHOLDERS: August 14,2013

  

    - 11 -

    

    

 

INTENSITY THERAPEUTICS, INC.

 

AMENDMENT NO. 1

TO

2013 STOCK AND OPTION PLAN

 

This Amendment
No. 1 (the “Amendment”) to the 2013 Stock and Option Plan dated August 14, 2013 (the “Plan”)
of Intensity Therapeutics, Inc., a Delaware corporation (the “Corporation”) is made as of the 25th day of August,
2014.

 

RECITALS:

 

WHEREAS, Section
6.1 of the Plan specifies the the total number of shares of Common Stock, $0.0001 par value (“Common Stock”),
available for issuance pursuant to the Plan; and

 

WHEREAS, the Sole
Director (the “Director”) of the Corporation desires to increase the aggregate number of shares of Common Stock,
$0.0001 par value, available for issuance under the Plan from One Hundred Fifty Thousand (150,000) to Four Hundred Thousand (400,000)
(the “Share Increase”). Capitalized terms used in this Amendment without definition shall have the meanings
assigned to such terms in the Plan; and

 

WHEREAS, pursuant
to Section 12.1 of the Plan and relevant provisions of the Internal Revenue Code of 1986, as amended, the Director of the Corporation
may amend the Plan to effect the Share Increase; and

 

WHEREAS, the Director
of the Corporation has approved this Amendment.

 

NOW, THEREFORE, it
is hereby agreed as follows:

 

1. That
the first sentence in Section 6.1 of the Plan is hereby amended by striking and deleting such sentence in its entirety and replacing it
with the following sentence in lieu thereof:

 

“Subject to
adjustment as provided in Section 10, the maximum number of Shares to be reserved for issuance under the Plan as Awards, including Incentive
Stock Options, shall be Four Hundred Thousand (400,000) Shares.”

 

2. Except
as expressly provided in this Amendment, the terms and provisions of the Plan remain unchanged and the Plan remains in full force and
effect in accordance with its original terms.

 

    

    

    

 

EXHIBIT A

 

INTENSITY THERAPEUTICS, INC.

 

AMENDMENT NO.2

TO

2013 STOCK AND OPTION PLAN

 

This Amendment No.
2 (the “Amendment”) to the 2013 Stock and Option Plan dated August 14, 2013 (the “Plan”)
of Intensity Therapeutics, Inc., a Delaware corporation (the “Corporation”) is made as of the 26th day
of June, 2015.

 

RECITALS:

 

WHEREAS,
the Sole Director (the “Director”) of the Corporation desires to increase the aggregate number of shares of
the Corporation’s Common Stock, $0.0001 par value, available for issuance under the Plan from Four Hundred Thousand ( 400,000)
to Nine Hundred Thousand (900,000) (the “Share Increase”). Capitalized terms used in this Amendment without
definition shall have the meanings assigned to such terms in the Plan; and

 

WHEREAS,
pursuant to Section 12.1 of the Plan and relevant provisions of the Internal Revenue Code of 1986, as amended, the Director of the Corporation
may amend the Plan to effect the Share Increase; and

 

WHEREAS, the Director of the Corporation has approved
this Amendment.

 

NOW, THEREFORE, it is hereby agreed as follows:

 

1. That the
first sentence in Section 6.1 of the Plan is hereby amended by striking and deleting such sentence in its entirety and replacing it with
the following sentence in lieu thereof:

 

“Subject to
adjustment as provided in Section 10, the maximum numoer of Shares to be reserved for issuance under the Plan as A wards, including Incentive
Stock Options, shall be Nine Hundred Thousand (900,000) Shares.”

 

2. Excert
as expressly provided in this Amendment, the terms and provisions of the Plan remain unchan~d and the Plan remains in full force and effect
in accordance with its original terms.

 

    

    

    

 

EXHIBIT A

 

INTENSITY
THERAPEUTICS, INC.

 

AMENDMENT NO. 3

TO

2013 STOCK AND OPTION PLAN

 

This Amendment No. 3 (the
“Amendment” to the 2013 Stock and Option Plan dated August 14, 2013 (the
“Plan”) of Intensity Therapeutics, Inc., a Delaware corporation (the “Corporation”)
is made as of the 25th day of August, 2016.

 

RECITALS:

 

WHEREAS,
the Board of Directors (the “Board”) of the Corporation desire
to increase the aggregate number of shares of the Corporations’ s Common Stock, $0.0001 par value, available for issuance under
the Plan from Nine Hundred Thousand (900,000) to One Million Eight Hundred Thousand (1,800,000) (the “Share
Increase”). Capitalized terms used in this Amendment without definition shall have the meanings assigned to such
terms in the Plan;

 

WHEREAS,
pursuant to Section 12.1 of the Plan and relevant provisions of the Internal Revenue Code of 1986, as amended, the Board may
amend the Plan to effect the Share Increase; and

 

WHEREAS, the
Board has approved this Amendment.

 

NOW, THEREFORE, it is hereby agreed as follows:

 

That the
first sentence in Section 6.1 of the Plan is hereby amended by striking and deleting such sentence in its entirety and replacing it with
the following sentence in lieu thereof:

 

“Subject
to adjustment as provided in Section 10, the maximum number of Shares to be reserved for issuance under the Plan as Awards, including
Incentive Stock Options, shall be One Million Eight Hundred Thousand (1,800,000) Shares.”

 

Except as
expressly provided in this Amendment, the terms and provisions of the Plan remain unchanged and the Plan remains in full force and effect
in accordance with its original terms.

 

    

    

    

 

INTENSITY THERAPEUTICS, INC.

 

AMENDMENT NO. 4

TO

2013 STOCK AND OPTION PLAN

 

This AMENDMENT TO THE 2013
STOCK AND OPTION PLAN (the “Amendment”), dated as of September 23, 2020 (the “Effective Date”),
is hereby adopted by Intensity Therapeutics, Inc., a Delaware corporation (the “Corporation”). Capitalized terms used
but not defined in this Amendment shall have the meanings assigned to them in the 2013 Stock and Option Plan (the “Plan”).

 

RECITALS

 

WHEREAS, Section 12.1 of the
Plan permits the Board of Directors (the “Board”) of the Corporation to amend the Plan from time to time, subject only
to certain limitations specified therein.

 

WHEREAS, the Board previously
deemed it in the best interests of the Corporation and its stockholders to increase the aggregate number of shares of the Corporation’s
Common Stock, $0.0001 par value available for issuance under the Plan from One Million Eight Hundred Thousand (1,800,000) to Four Million
Five Hundred Thousand (4,500,000) (the “Increase”).

 

NOW, THEREFORE, the following
amendments and modifications are hereby made a part of the Plan:

 

AMENDMENT:

 

1. The first sentence of Section
6.1 of the Plan is hereby amended by deleting such sentence in its entirety and replacing it with the following sentence in lieu thereof:

 

“Subject to
adjustment as provided in Section 10, the maximum number of Shares to be reserved for issuance under the Plan as Awards, including Incentive
Stock Options, shall be Four Million Five Hundred Thousand (4,500,000) Shares.”

 

2. Except
as specifically amended hereby, all of the terms and other provisions of the Plan are hereby ratified and confirmed and shall continue
to be in full force and effect in accordance with their respective terms on the date hereof.

 

[Signature Page Follows]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]